美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tevogen Bio Holdings Inc.

0.0358

-0.0020-5.29%

盘后：0.03650.0007+1.96%19:59 EDT

成交量：8.98万

成交额：3,050.12

市值：704.20万

市盈率：-0.17

高：0.0400

开：0.0400

低：0.0270

收：0.0378

52周最高：0.0800

52周最低：0.0253

股本：1.97亿

流通股本：1.97亿

量比：0.59

换手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-0.2138

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Tevogen.AI 宣布 Predictcell™ Beta 版取得新进展，精准度指标提升并扩展专有AI基础设施

Tevogen Bio Holdings 评估收购 Sciometrix 及 Clinicus 平台以监测长期新冠症状

Tevogen Bio Holdings Inc.盘中异动快速跳水5.01%

Tevogen推进仿制药战略，签署意向书评估收购Apozeal制药的潜在可能

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TVGNW"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0358,"timestamp":1776715200000,"preClose":0.037799,"halted":0,"volume":89755,"hourTrading":{"tag":"盘后","latestPrice":0.0365,"preClose":0.0358,"latestTime":"19:59 EDT","volume":1065,"amount":38.616235,"timestamp":1776729586967,"change":0.0007,"changeRate":0.019553,"amplitude":0.027933},"delay":0,"changeRate":-0.05288499695759149,"floatShares":196705066,"shares":196705066,"eps":-0.2138,"marketStatus":"已收盘","change":-0.001999,"latestTime":"04-20 16:00:00 EDT","open":0.04,"high":0.04,"low":0.027,"amount":3050.12405988,"amplitude":0.343924,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.2138,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776758400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.037799,"preHourTrading":{"tag":"盘前","latestPrice":0.0347,"preClose":0.031,"latestTime":"09:11 EDT","volume":100,"amount":3.47,"timestamp":1776690698382,"change":0.0037,"changeRate":0.119355,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.0365,"preClose":0.0358,"latestTime":"19:59 EDT","volume":1065,"amount":38.616235,"timestamp":1776729586967,"change":0.0007,"changeRate":0.019553,"amplitude":0.027933},"volumeRatio":0.588991},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":196705066,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.588991,"shares":196705066,"dividePrice":0,"high":0.04,"amplitude":0.343924,"preClose":0.037799,"low":0.027,"week52Low":0.0253,"pbRate":"--","week52High":0.08,"institutionHeld":0,"latestPrice":0.0358,"eps":-0.2138,"divideRate":0,"volume":89755,"delay":0,"ttmEps":-0.2138,"open":0.04,"prevYearClose":0.0422,"prevWeekClose":0.0378,"prevMonthClose":0.0339,"prevQuarterClose":0.0339,"fiveDayClose":0.0318,"twentyDayClose":0.036,"sixtyDayClose":0.0443},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGNW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165653461","title":"Tevogen.AI 宣布 Predictcell™ Beta 版取得新进展，精准度指标提升并扩展专有AI基础设施","url":"https://stock-news.laohu8.com/highlight/detail?id=1165653461","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165653461?lang=zh_cn&edition=fundamental","pubTime":"2026-03-14 00:31","pubTimestamp":1773419470,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings (TVGN) 近日披露了其人工智能平台 Predictcell™ Beta 版本的多项重要进展。该版本在精准度指标上展现出显著优化，同时公司还进一步扩展了其专有的AI基础设施架构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGNW","TVGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123137439","title":"Tevogen Bio Holdings 评估收购 Sciometrix 及 Clinicus 平台以监测长期新冠症状","url":"https://stock-news.laohu8.com/highlight/detail?id=1123137439","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123137439?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 03:16","pubTimestamp":1773256571,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. 正在考虑收购 Sciometrix 和 Clinicus 平台，旨在加强对长期新冠（Long Covid）的监测能力。此举显示该公司正积极拓展其在生物科技领域的布局，特别是在应对新冠后遗症方面寻求新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618118139","title":"Tevogen Bio Holdings Inc.盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618118139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618118139?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 21:41","pubTimestamp":1773236461,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时41分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水5.01%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司，利用CD8细胞毒性T淋巴细胞，开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214101a6b84e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311214101a6b84e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135990684","title":"Tevogen推进仿制药战略，签署意向书评估收购Apozeal制药的潜在可能","url":"https://stock-news.laohu8.com/highlight/detail?id=1135990684","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135990684?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 03:51","pubTimestamp":1772740289,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings（简称Tevogen）近日在仿制药业务布局上迈出关键一步，公司已签署意向书，正式启动对Apozeal制药的潜在收购评估。此举标志着Tevogen正加速拓展其仿制药产品线，以强化在生物医药领域的市场竞争力。通过本次战略评估，Tevogen有望进一步整合行业资源，提升其在全球仿制药市场的份额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN","TVGNW"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TVGNW\",params:#limit:6,delay:false,,,undefined,":[]}}